HOPPER JONATHAN MARK (Chief Medical Officer) sold 4.4% of their position (3.47K shares) of VERICEL CORP on the open market
Open‑market sale worth $121.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001140361-26-013334
Officer· Chief Medical Officer
Since Feb 2020
+3.47K
Net shares
Net buyer
$121.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.94K acquired · 3.47K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.47K
Price / share
$10.95
Trade value
$38.02K
% of position
4.6%
4/2/2026
75.56K→79.03K
Common Stock
Direct
Shares
−3.47K
Price / share
$35.00
Trade value
$121.52K
% of position
4.4%
4/2/2026
79.03K→75.56K
Total
Net shares
+0.00
Net value
-$83.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/2/2026 | M · Option Exercise | +3.47K | $10.95 | $38.02K | 4.6% | 75.56K | 79.03K |
| Common Stock Direct | 4/2/2026 | S · Sale | −3.47K | $35.00 | $121.52K | 4.4% | 79.03K | 75.56K |
| Total | +0.00 | -$83.50K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.47K shares
Shares
+3.47K
Strike price
10.95
Held after
9.13K
Exercisable
—
4/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.47K shares | 4/2/2026 | M · Option Exercise | +3.47K | 10.95 | — | 9.13K |